Comparison of troponin 1 level among the patients who underwent coronary artery bypass grafting with and without adenosine as an adjunct to blood cardioplegia


  • Kishore Lal J. Department of Cardiovascular Thoracic Surgery, Medical College Hospital, Thiruvananthapuram, Kerala, India
  • Vinu C. V. Department of Cardiovascular Thoracic Surgery, Medical College Hospital, Thiruvananthapuram, Kerala, India
  • Abdul Rasheed M. H. Principal, Government Medical College, Paripally, Kollam, Kerala, India
  • Sony P. S. Department of Cardiovascular Thoracic Surgery, Medical College Hospital, Thiruvananthapuram, Kerala, India



Coronary artery bypass graft, Cardioplegia, Ejection fraction


Background: Cellular injury is not avoidable with current cardioplegic solutions. No method of cardioplegia has been shown to completely protect the myocardium against cellular injury. The objective of the study is to evaluate the safety and efficacy of adenosine as an adjunct to blood cardioplegia during CABG.

Methods: A retrospective study at GMCT, Thiruvananthapuram in CABG patients for 3 years from January 1, 2016, to December 31, 2019, between the age of 40 and 70 years. Patients with other chronic diseases and pre-operative echo showing EF less than 40% were excluded. The study variables were level of troponin I intra and postoperative period, time taken for cardiac standstill, number of days in ventilator, ICU and on inotropic supports. Also, postoperative lactate levels, changes in RWMA and EF.

Results: Of the total 75 subjects, 40 got adenosine while 35 didn’t. The mean post op EF for those who got adenosine is 55.30 and without is 56.46. The mean time of cardiac stand still with adenosine is 12.88 sec and without is 16.51 sec. The mean post op troponin I level in those who got adenosine is 6.43 and without is 12.94.

Conclusions: Decreased level of troponin I and inotropic requirement suggests that an optimal myocardial protection. Adenosine usage helps in early extubation but doesn’t alter the number of days in ICU. Adenosine is safe, gives more rapid cardiac arrest but it will not alter the post op left ventricular function.

Author Biography

Kishore Lal J., Department of Cardiovascular Thoracic Surgery, Medical College Hospital, Thiruvananthapuram, Kerala, India

Associate professor,

Department of Cardiovascular and thoracic surgery,

Government Medical college



Carrel A. On the experimental surgery of the thoracic aorta and heart. Ann surg. 1910;52:83-95.

Goetz RH, Rohman M, Haller JD. Internal mammary-coronary artery anastomosis. A nonsuture method employing tantalum rings. J thorac cardiovasc surg. 1961;41:378-86.

Sabiston DC, William F. Rienhoff Jr. The coronary circulation. Johns Hopkins Med J. 1974;134:314-29.

Clermont G, Vergely C, Jazayeri S, Lahet JJ, Goudeau JJ, Lecour S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology. 2002;96:80-7.

Tavares-murta BM, Crdeiro AO, Murta EF, Cunha FDEQ, Bisinotto FM. Effect of myocardial protection and perfusion temperature on production of cytokines and nitric oxide during cardiopulmonary bypass. Acta Cir Bras. 2007;22:243-50.

Berg K, Haaverstad R, Astudillo R, Bjӧrngaard M, Skarra S, Wiseth R, et al. Oxidative stress during coronary artery bypass operations: importance of surgical trauma and drug treatment. Scand Cardiovasc J. 2006;40:291-7.

Buckberg GD, Brazier Jr, Nelson RL, Goldstein SM, Mcconnell DH, Cooper N. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart. J Thorac Cardiovasc Surg. 1977;73:87-94.

Belardinelli, Llinden J, Berne RM. the cardiac effects of adenosine. Prog cardiovasc dis. 1989;32:73-97.

Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ res. 1980;47:807-13.

Ely SW, berne RM. Protective effects of adenosine in myocardial ischemia. Circulation. 1992;85:893-904.

Rinne T, Laurikka J, Penttilä I, Kaukinen S. Adenosine with cold blood cardioplegia during coronary revascularization. Journal of cardiothoracic and vascular surgery. 2000;14(1):18-20.

Jin ZX, Zhou JJ, Xin M, Peng DR, Wang XM, Bi SH, Wei Xf, Yi DH. Postconditioning the human heart with adenosine in heart valve replacement surgery. Annals of thoracic surgery. 2007;83(6):2066-72.

Ghasemi F, Azarfarin R, Salahi S, Baharestani B, Ghavidel A. The effects of cold blood cardioplegia with and without adenosine on hemodynamic status of patients undergoing mitral valve surgery. Multidiscip Cardio Annal. 2020;11(1):e96919.

Jakobsen O, Næsheim T, Nergard K, Sørlie, Steensrud T. Adenosine instead of supranormal potassium in cardioplegia: it is safe, efficient, and reduces the incidence of postoperative atrial fibrillation. A randomized clinical trial. The journal of thoracic and cardiovascular surgery. 2013.

Liu R, Xing J, Miao N, Li W, Liu W, Lai YQ et al. The myocardial protective effect of adenosine as an adjunct to intermittent blood cardioplegia during open heart surgery european journal of cardio-thoracic surgery. 2009;36(6):1018-23.

Idris MR. Effect of adenosine on myocardial protection as an adjunct to cardioplegia during coronary artery bypass surgery. Heart J. 2018;14(1).

Kaliti JP. Fast induction of myocardial arrest by bolus injection of adenosine at aortic root in patients with “sick heart” undergoing cardiac surgery enhances myocardial protection international journal of science research. 2016;5(8):2277-8179.






Original Research Articles